Home › Funds › Column Group LLC › SRZN

Column Group LLC position in SRZN

SURROZEN INC · Health Care

Column Group LLC reported holding 1,916,950 shares of SRZN (SURROZEN INC) in its Q2 2026 13F filing — a position valued at US$49.7M, representing 56.46% of its reported portfolio and ranking #1 among its reported holdings. Column Group LLC has disclosed SRZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.92M sh
Reported value held$49.74M
Portfolio Weight56.46%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Column Group LLC's SRZN position evolved

Column Group LLC first disclosed a stake in SRZN in Q3 2023 at 9,414,795 shares (US$4.6M). The position peaked in Q1 2026 at 1,916,950 shares, worth US$55.8M. Across 12 filings, Column Group LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,916,950 shares valued at US$49.7M. Notable position changes include a 93% trim in Q4 2023 (shares rose 67% over the following quarter), a 31% increase in Q2 2024 (shares rose 9% over the following quarter), a 85% increase in Q1 2025 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.41M $4.61M New
Q4 2023 627.65K $5.90M Reduce
Q1 2024 616.54K $9.69M Reduce
Q2 2024 810.09K $8.87M Add
Q3 2024 810.09K $9.70M Hold
Q4 2024 810.09K $11.62M Hold
Q1 2025 1.50M $17.49M Add
Q2 2025 1.50M $13.41M Hold
Q3 2025 1.50M $19.33M Hold
Q4 2025 1.85M $41.84M Add
Q1 2026 1.92M $55.84M Add
Q2 2026 1.92M $49.74M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SRZN and 13F data

SRZN (SURROZEN INC) is a Health Care company. 51 other funds we track also report a position in SRZN — the largest reported positions include TCG Crossover Management, LLC (US$38.2M), Boxer Capital Management, LLC (US$27.0M), Venrock Adviser, LLC (US$16.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SRZN

All SRZN fund holders →

FAQ

How long has Column Group LLC held SRZN?

Column Group LLC has disclosed SRZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Column Group LLC's current position in SRZN?

As of Q2 2026, Column Group LLC holds 1.92M shares of SRZN (SURROZEN INC), valued at $49.74M, representing 56.46% of its reported portfolio and ranking #1.

Has Column Group LLC been buying or selling SRZN?

In the latest 13F filing (Q2 2026), Column Group LLC held unchanged its position in SRZN. The position peaked in Q1 2026 at 1.92M shares.

Which other funds hold SRZN?

Other major institutional holders of SRZN include TCG Crossover Management, LLC, Boxer Capital Management, LLC, Venrock Adviser, LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.